APA (7th ed.) Citation

CM, S., CH, L., MC, H., PF, Y., FT, H., RF, L., & LC, H. (2022). Reinforcement of Sorafenib Anti-osteosarcoma Effect by Amentoflavone Is Associated With the Induction of Apoptosis and Inactivation of ERK/NF-κB. In vivo (Athens, Greece), 36(3), 1136. https://doi.org/10.21873/invivo.12812

Chicago Style (17th ed.) Citation

CM, Su, Li CH, Huang MC, Yueh PF, Hsu FT, Lin RF, and Hsu LC. "Reinforcement of Sorafenib Anti-osteosarcoma Effect by Amentoflavone Is Associated With the Induction of Apoptosis and Inactivation of ERK/NF-κB." In Vivo (Athens, Greece) 36, no. 3 (2022): 1136. https://doi.org/10.21873/invivo.12812.

MLA (9th ed.) Citation

CM, Su, et al. "Reinforcement of Sorafenib Anti-osteosarcoma Effect by Amentoflavone Is Associated With the Induction of Apoptosis and Inactivation of ERK/NF-κB." In Vivo (Athens, Greece), vol. 36, no. 3, 2022, p. 1136, https://doi.org/10.21873/invivo.12812.